[1] 唐秋,胡巧英.肿瘤标志物循环微小RNA的临床研究现状[J].国际肿瘤学杂志,2015,42(11):832-834.
[2] BHAT S S,JARMOLOWSKI A,SZWEYKOWSKA-KULIŃSKA Z,et al.MicroRNA biogenesis:Epigenetic modifications as another layer of complexity in the microRNA expression regulation[J].Acta Biochim Pol,2016,63(4):717-723.
[3] TSIALIKAS J,ROMENS M A,ABBOTT A,et al.Stage-specific timing of the microRNA regulation of lin-28 by the heterochronic gene lin-14 in gaenorhabditis elegans[J].Genetics,2017,205(1):251-262.
[4] TANAKA R,TOMOSUGI M,SAKAI T,et al.MEK inhibitor suppresses expression of the miR-17-92 cluster with G1-phase arrest in HT-29 human colon cancer cells and mIA PaCa-2 pancreatic cancer cells[J].Anticancer Res,2016,36(9):4537-4543.
[5] HERNANDEZ-ALCOCEBA R,FORTES P.Cancer stem cell-associated microRNAs:searching for markers and targets in hepatocellular carcinoma[J].Transl Gastroenterol Hepatol,2016,16:1-16.
[6] MANSOUR M R,SANDA T,LAWTON L N,et al.The TAL1 complex targets the FBXW7 tumor suppressor by activating miR-223 in human T cell acute lymphoblastic leukemia[J].J Exp Med,2013,210:1545-1557.
[7] ROKAH O H,GRANOT G,OVCHARENKO A,et al.Downregulation of Mir-31,Mir-155,and Mir-564 in chronic myeloid leukemia cells[J].PLoS One,2012,7:e35501.
[8] 林桐,张启国,吴鸿雁,等.多发性骨髓瘤患者骨髓组织中NF-κB/p65的表达与硼替佐米疗效的关系[J].东南大学学报:医学版,2016,35(1):41-45.
[9] WONG K Y,YIM R L,KWONG Y L,et al.Epigenetic inactivation of the MIR129-2 in hematological malignancies[J].Hematol Oncol,2013,6:16.
[10] LI Y,LIU S,ZHANG F,et al.Expression of the microRNAs hsa-miR-15a and hsa-miR-16-1 in lens epithelial cells of patients with age-related cataract[J].Int J Clin Exp Med,2015,8(2):2405-2410.
[11] ACUNZO M,CROCE C M.Downregulation of miR-15a and miR-16-1 at 13q14 in chronic lymphocytic leukemia[J].Clin Chem,2016,62(4):655-656.
[12] HAO M,ZANG M,ZHAO L,et al.Serum high expression of miR-214 and miR-135b as novel predictor for myeloma bone disease development and prognosis[J].Oncotarget,2016,7(15):19589-19600.
[13] ANDERSSON K M,TURKKILA M,ERLANDSSON M C,et al.Survivin controls biogenesis of microRNA in smokers:a link to pathogenesis of rheumatoid arthritis[J].Biochim Biophys Acta,2017,1863(3):663-673.
[14] YANG Y,PAN Q,SUN B,et al.miR-29b targets LPL and TDG genes and regulates apoptosis and triglyceride production in MECs[J].DNA Cell Biol,2016,35(12):758-765.
[15] ZHAO Y,SONG Y,YAO L,et al.Circulating microRNAs:promising biomarkers involved in several cancers and other diseases[J].DNA Cell Biol,2017,36(2):77-94.
[16] KRISTENSEN L S,HANSEN J W,KRISTENSEN S S,et al.Aberrant methylation of cell-free circulating DNA in plasma predicts poor outcome in diffuse large B cell lymphoma[J].Clin Epigenetics,2016,8(1):95.
[17] BARCISZEWSKA A M.MicroRNAs as efficient biomarkers in high-grade gliomas[J].Folia Neuropathol,2016,54(4):369-374.
[18] XU L H,GUO Y,ZHANG X L,et al.Blood-based circulating microRNAs are potential diagnostic biomarkers for leukemia:result from a Meta-analysis[J].Cell Physiol Biochem,2016,38(3):939-949.
[19] LI J,ZHAI X W,WANG H S,et al.Circulating microRNA-21,microRNA-23a,and microRNA-125b as biomarkers for diagnosis and prognosis of burkitt lymphoma in children[J].Med Sci Monit,2016,19(22):4992-5002.
[20] PIZZAMIGLIO S,ZANUTTO S,CINISELLI C M,et al.A methodological procedure for evaluating the impact of hemolysis on circulating microRNAs[J].Oncol Lett,2017,13(1):315-320.
[21] KUBICZKOV L,KRYUKOV F,SLABY O,et al.Circulating serum microRNAs as novel diagnostic and prognostic biomarkers for multiple myeloma and monoclonal gammopathy of undetermined significance[J].Haematologica,2014,99:511-518.
[22] PICHIORRI F,SUH S S,ROCCI A,et al.Downregulation of p53-inducible microRNAs 192,194,and 215 impairs the p53/MDM2 autoregulatory loop in multiple myeloma development[J].Cancer Cell,2016,30(2):349-351.
[23] GAO X,ZHANG R,QU X,et al.MiR-15a,miR-16-1 and miR-17-92 cluster expression are linked to poor prognosis in multiple myeloma[J].Leuk Res,2012,36(12):1505-1509.
[24] LUETKENS T,YOUSEF S,RADHAKRISHNAN S V,et al.Current strategies for the immunotherapy of multiple myeloma[J].Oncology (Williston Park),2017,31(1):55-63.
[25] BANERJEE N,BANDYOPADHYAY A K,DUTTA S,et al.Increased microRNA 21 expression contributes to arsenic induced skin lesions,skin cancers and respiratory distress in chronically exposed individuals[J].Toxicology,2017,378:10-16.
[26] LI Y,DU Z,WANG X,et al.Association of IL-6 promoter and receptor polymorphisms with multiple myeloma risk:a systematic review and Meta-analysis[J].Genet Test Mol Biomarkers,2016,20(10):587-596.
[27] RUI M,QU Y,GAO T,et al.Simultaneous delivery of anti-miR21 with doxorubicin prodrug by mimetic lipoprotein nanoparticles for synergistic effect against drug resistance in cancer cells[J].Int J Nanomedicine,2016,12:217-237.
[28] MATTHES T,MANFROI B,HUARD B,et al.Revisiting IL-6 antagonism in multiple myeloma[J].Crit Rev Oncol Hematol,2016,105:1-4.
[29] LI Y,ZHANG B,LI W,et al.MiR-15a/16 regulates the growth of myeloma cells,angiogenesis and antitumor immunity by inhibiting Bcl-2,VEGF-A and IL-17 expression in multiple myeloma[J].Leuk Res,2016,49:73-79.
[30] GRECO C,VITELLI G,VERCILLO G,et al.Reduction of serum IGF-I levels in patients affected with monoclonal gammopathies of undetermined significance or multiple myeloma.Comparison with bFGF,VEGF and K-ras gene mutation[J].J Exp Clin Cancer Res,2009,10(28):35.
[31] GUPTA V A,MATULIS S M,CONAGE-POUGH J E,et al.Bone marrow microenvironment derived signals induce Mcl-1 dependence in multiple myeloma[J].Blood,2017,129(14):1969-1979.
[32] MALCOVATI L,CAZZOLA M.The shadowlands of MDS:idiopathic cytopenias of undetermined significance (ICUS) and clonal hematopoiesis of indeterminate potential (CHIP)[J].Hematology Am Soc Hematol Educ Program,2015,2015:299-307.
[33] 李爽.蛋白酶体抑制剂硼替佐米在多发性骨髓瘤中的耐药机制[J].白血病·淋巴瘤,2016,25(4):246-249.
[34] ROKAVEC M,LI H,JIANG L,et al.The p53/miR-34 axis in development and disease[J].J Mol Cell Biol,2014,6(3):214-130.
[35] di MARTINO M T,LEONE E,AMODIO N,et al.Synthetic miR-34a mimics as a novel therapeutic agent for multiple myeloma:in vitro and in vivo evidence[J].Clin Cancer Res,2012,18:6260-6270.
[36] SUN T Y,XIE H J,LI Z,et al.miR-34a regulates HDAC1 expression to affect the proliferation and apoptosis of hepatocellular carcinoma[J].Am J Transl Res,2017,9(1):103-114.
[37] LING X H,CHEN Z Y,LUO H W,et al.BCL9,a coactivator for Wnt/β-catenin transcription,is targeted by miR-30c and is associated with prostate cancer progression[J].Oncol Lett,2016,11(3):2001-2008.
[38] YANG Y,PAN Q,SUN B,et al.miR-29b targets LPL and TDG genes and regulates apoptosis and triglyceride production in MECs[J].DNA Cell Biol,2016,35(12):758-765.
[39] ZHANG K,CAI H X,GAO S,et al.TNFSF15 suppresses VEGF production in endothelial cells by stimulating miR-29b expression via activation of JNK-GATA3 signals[J].Oncotarget,2016,7(43):69436-69449.
[40] HYSOLLI E,TANAKA Y,SU J,et al.Regulation of the DNA methylation landscape in human somatic cell reprogramming by the miR-29 family[J].Stem Cell Reports,2016,7(1):43-54. |
